BioCentury
ARTICLE | Clinical News

Aurograb: Phase IIa

January 20, 2003 8:00 AM UTC

In a U.K. Phase IIa study in 8 patients with MRSA sepsis, NeuTec said Aurograb in combination with vancomycin did not result in any toxicity concerns. ...